Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Hurteau J, Grayeski M, Dixon J. BEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer. Gynecol Oncol 2026;215:164-167.
PMID: 43013925


Privacy Policy